Evidence map›Paper›PMID 25845696›Full record

ArticleSleep2015

Promotion of Wakefulness and Energy Expenditure by Orexin-A in the Ventrolateral Preoptic Area.

Vijayakumar Mavanji, Claudio E Perez-Leighton, Catherine M Kotz, Charles J Billington, Sairam Parthasarathy, Christopher M Sinton, Jennifer A Teske

Open access · bronzeAbstract read
In one paragraph

Article in Sleep, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Cerebrospinal-fluid Orexin-A levels in different neurocognitive disorders: a comparison study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  3. Sleep deprivation engages the orexin/hypocretin system to regulate food reward seeking.The international journal of neuropsychopharmacology · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Physiological Role of Orexinergic System for Health.International journal of environmental research and public health · 2022
    Review
  15. Article
  16. Roles of Neuropeptides in Sleep-Wake Regulation.International journal of molecular sciences · 2022
    Review
  17. Review
  18. Orexin, serotonin, and energy balance.WIREs mechanisms of disease · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Vijayakumar MavanjiMinneapolis VA Health Care System, Minneapolis, MN.
Claudio E Perez-LeightonCenter for Integrative Medicine and Innovative Science, Universidad Andres Bello, Santiago, Chile.
Catherine M KotzMinneapolis VA Health Care System, Minneapolis, MN.
Charles J BillingtonMinneapolis VA Health Care System, Minneapolis, MN.
Sairam ParthasarathyArizona Respiratory Center University of Arizona, Tucson, AZ.
Christopher M SintonArizona Respiratory Center University of Arizona, Tucson, AZ.
Jennifer A TeskeDepartment of Nutritional Sciences, University of Arizona, Tucson, AZ.
Minneapolis VA Health Care System · USUniversity of Arizona · USArizona Science Center · USGeriatric Research Education and Clinical Center · USUniversidad Andrés Bello · CL

Funding

PREDOCTORAL TRAINING OF NEUROSCIENTISTST32GM008471 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI EBNER, TIMOTHY J · 1993 to 2017
$4.9M
Role of Variability in SPA in Susceptibility to ObesityR01DK100281 · NIDDK · UNIVERSITY OF MINNESOTA · PI KOTZ, CATHERINE M · 2014 to 2017
$1.1M
NIDDK NIH HHS 1R01DK100281-01A1NIDDK NIH HHS 5P30DK05045619NIGMS NIH HHS T32 GM008471
6 · The paper itself

Abstract

STUDY

objectivesThe ventrolateral preoptic area (VLPO) and the orexin/hypocretin neuronal system are key regulators of sleep onset, transitions between vigilance states, and energy homeostasis. Reciprocal projections exist between the VLPO and orexin/hypocretin neurons. Although the importance of the VLPO to sleep regulation is clear, it is unknown whether VLPO neurons are involved in energy balance. The purpose of these studies was to determine if the VLPO is a site of action for orexin-A, and which orexin receptor subtype(s) would mediate these effects of orexin-A. We hypothesized that orexin-A in the VLPO modulates behaviors (sleep and wakefulness, feeding, spontaneous physical activity [SPA]) to increase energy expenditure. DESIGN AND MEASUREMENTS: Sleep, wakefulness, SPA, feeding, and energy expenditure were determined after orexin-A microinjection in the VLPO of male Sprague-Dawley rats with unilateral cannulae targeting the VLPO. We also tested whether pretreatment with a dual orexin receptor antagonist (DORA, TCS-1102) or an OX2R antagonist (JNJ-10397049) blocked the effects of orexin-A on the sleep/wake cycle or SPA, respectively.

resultsOrexin-A injected into the VLPO significantly increased wakefulness, SPA, and energy expenditure (SPA-induced and total) and reduced NREM sleep and REM sleep with no effect on food intake. Pretreatment with DORA blocked the increase in wakefulness and the reduction in NREM sleep elicited by orexin-A, and the OX2R antagonist reduced SPA stimulated by orexin-A.

conclusionsThese data show the ventrolateral preoptic area is a site of action for orexin-A, which may promote negative energy balance by modulating sleep/wakefulness and stimulating spontaneous physical activity and energy expenditure.

Indexed as

AnimalsAttentionDioxanesEatingEnergy MetabolismMaleNeuronsOrexin Receptor AntagonistsOrexin ReceptorsOrexinsPhenylurea CompoundsPreoptic AreaRatsRats, Sprague-DawleySleepSleep DeprivationDioxanesJNJ 10397049Orexin Receptor AntagonistsOrexin ReceptorsOrexinsPhenylurea Compoundsarousalbrainobesitysleep

Identifiers

PMID25845696
PMCPMC4531404
OpenAlexW290424080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.